Depression & Anxiety | ICHOM – International Consortium for Health Outcomes Measurement
Depression & Anxiety

Depression & Anxiety

The ICHOM Standard Set for Depression & Anxiety is the result of hard work by a group of leading physicians, measurement experts, and patients. It represents the outcomes that matter most to patients with depression and/or anxiety. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.
Depression & Anxiety

1 Recommended to track via the Patient Health Questionnaire (PHQ-9).
2 Includes symptoms of general anxiety, social phobia, agoraphobia, post-traumatic stress disorder, panic disorder, and obsessive-compulsive disorder.
3 Recommended to track via the Generalized Anxiety Disorder (GAD-7), and for those with specific anxiety disorders: the Social Phobia Inventory (SPIN), the Mobility Inventory for Agoraphobia (MIA), the Impact of Event Scale - Revised for Post-Traumatic Stress Disorder (IES-R), the Panic Disorder Severity Scale (PDSS-SR), and the Obsessive-Compulsive Inventory (OCI-R).
4 Recommended to track via the World Health Organization Disability Assessment 2.0 (WHODAS 2.0).
5 Includes work status and disease-related absenteeism

© 2015 ICHOM. All rights reserved. When using this set of outcomes, or quoting therefrom, in any way, we solely require that you always make a reference to ICHOM as the source so that this organization can continue its work to define more standard outcome sets.

Team that developed this standard


Maria Kangas | Centre for Emotional Health, Macquarie University


Roberta Alvarenga Reis | Universidade Federal do Rio Grande do Sul


Anne Crocker | Douglas Mental Health University Institute, McGill University
Lucie Langford*
Alain Lesage | University of Montreal


Graciela Rojas | University of Chile


Sandra Nolte | Charité Universitätsmedizin Berlin
Alexander Obbarius | Charité Universitätsmedizin Berlin
Matthias Rose | Charité Universitätsmedizin Berlin


Vikram Patel | London School of Hygiene and Tropical Medicine


Toshi A. Furukawa | Kyoto University


Edwin de Beurs | Stichting Benchmark GGZ 
Paul Emmelkamp | University of Amsterdam


Erik Hedman | Karolinska Institutet


Doris M. Mwesigire | Makerere University

United Kingdom

David M. Clark | University of Oxford
David Smithson* | Anxiety UK

United States

Lee Baer | Harvard Medical School; Massachusetts General Hospital
Kelly Woolaway-Bickel | Department of the U.S. Army, Office of the Surgeon General
Paul A. Pilkonis | University of Pittsburgh
Harold A. Pincus | Columbia University
Cathy Sherbourne | The RAND Corporation

*Patient representative

Receive Updates

Reference Guide

A complete overview of the ICHOM Standard Set, including definitions for each measure and selected PROM instruments, time points for collection, and associated risk factors is available here:


Version 2.3.1: April 10th, 2017

3 MB

Get the Flyer

2,2 MB

Get the Database

40 KB

How to measure?

Interested in measuring the ICHOM Standard Set? Learn how to measure.

View launch materials here for more information.